151 related articles for article (PubMed ID: 23546025)
1. Comparison of risk of malignancy indices in evaluating ovarian masses in a Southeast Asian population.
Ong C; Biswas A; Choolani M; Low JJ
Singapore Med J; 2013 Mar; 54(3):136-9. PubMed ID: 23546025
[TBL] [Abstract][Full Text] [Related]
2. Role of a risk of malignancy index in clinical approaches to adnexal masses.
Simsek HS; Tokmak A; Ozgu E; Doganay M; Danisman N; Erkaya S; Gungor T
Asian Pac J Cancer Prev; 2014; 15(18):7793-7. PubMed ID: 25292065
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the diagnostic accuracy of International Ovarian Tumor Analysis simple rules and the risk of malignancy index to discriminate between benign and malignant adnexal masses.
Auekitrungrueng R; Tinnangwattana D; Tantipalakorn C; Charoenratana C; Lerthiranwong T; Wanapirak C; Tongsong T
Int J Gynaecol Obstet; 2019 Sep; 146(3):364-369. PubMed ID: 31206642
[TBL] [Abstract][Full Text] [Related]
4. Risk of malignancy index used as a diagnostic tool in a tertiary centre for patients with a pelvic mass.
Håkansson F; Høgdall EV; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Høgdall C;
Acta Obstet Gynecol Scand; 2012 Apr; 91(4):496-502. PubMed ID: 22229703
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two malignancy risk indices based on serum CA125, ultrasound score and menopausal status in the diagnosis of ovarian masses.
Morgante G; la Marca A; Ditto A; De Leo V
Br J Obstet Gynaecol; 1999 Jun; 106(6):524-7. PubMed ID: 10426607
[TBL] [Abstract][Full Text] [Related]
6. Risk of malignancy index in the preoperative evaluation of pelvic masses.
Obeidat BR; Amarin ZO; Latimer JA; Crawford RA
Int J Gynaecol Obstet; 2004 Jun; 85(3):255-8. PubMed ID: 15145261
[TBL] [Abstract][Full Text] [Related]
7. Ovarian fibroma/fibrothecoma: retrospective cohort study shows limited value of risk of malignancy index score.
Numanoglu C; Kuru O; Sakinci M; Akbayır O; Ulker V
Aust N Z J Obstet Gynaecol; 2013 Jun; 53(3):287-92. PubMed ID: 23611791
[TBL] [Abstract][Full Text] [Related]
8. A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer - An international multicenter study in women with an ovarian mass.
Karlsen MA; Høgdall EV; Christensen IJ; Borgfeldt C; Kalapotharakos G; Zdrazilova-Dubska L; Chovanec J; Lok CA; Stiekema A; Mutz-Dehbalaie I; Rosenthal AN; Moore EK; Schodin BA; Sumpaico WW; Sundfeldt K; Kristjansdottir B; Zapardiel I; Høgdall CK
Gynecol Oncol; 2015 Sep; 138(3):640-6. PubMed ID: 26086566
[TBL] [Abstract][Full Text] [Related]
9. Comparisons of Effectiveness in Differentiating Benign from Malignant Ovarian Masses between Conventional and Modified Risk of Malignancy Index (RMI).
Tantipalakorn C; Tinnangwattana D; Lerthiranwong T; Luewan S; Tongsong T
Int J Environ Res Public Health; 2023 Jan; 20(1):. PubMed ID: 36613208
[TBL] [Abstract][Full Text] [Related]
10. A prospective study to evaluate the risk malignancy index and its diagnostic implication in patients with suspected ovarian mass.
Dora SK; Dandapat AB; Pande B; Hota JP
J Ovarian Res; 2017 Aug; 10(1):55. PubMed ID: 28806987
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic extended usefulness of RMI: comparison of four risk of malignancy index in preoperative differentiation of borderline ovarian tumors and benign ovarian tumors.
Zhang S; Yu S; Hou W; Li X; Ning C; Wu Y; Zhang F; Jiao YF; Lee LTO; Sun L
J Ovarian Res; 2019 Sep; 12(1):87. PubMed ID: 31526390
[TBL] [Abstract][Full Text] [Related]
12. A multicenter clinical trial validating the performance of HE4, CA125, risk of ovarian malignancy algorithm and risk of malignancy index.
Lycke M; Kristjansdottir B; Sundfeldt K
Gynecol Oncol; 2018 Oct; 151(1):159-165. PubMed ID: 30149898
[TBL] [Abstract][Full Text] [Related]
13. Comparison of risk of malignancy indices; RMI 1-4 in borderline ovarian tumor.
Yenen MC; Alanbay I; Aktürk E; Ercan CM; Coksuer H; Karaşahin E; Ozan H; Dede M
Eur J Gynaecol Oncol; 2012; 33(2):168-73. PubMed ID: 22611957
[TBL] [Abstract][Full Text] [Related]
14. The risk of malignancy index (RMI) in diagnosis of ovarian malignancy.
Moolthiya W; Yuenyao P
Asian Pac J Cancer Prev; 2009; 10(5):865-8. PubMed ID: 20162854
[TBL] [Abstract][Full Text] [Related]
15. A risk of malignancy index in preoperative diagnosis of ovarian cancer.
Ma S; Shen K; Lang J
Chin Med J (Engl); 2003 Mar; 116(3):396-9. PubMed ID: 12781045
[TBL] [Abstract][Full Text] [Related]
16. Predictive Value of Malignancy Risk Indices for Ovarian Masses in Premenopausal and Postmenopausal Women.
Ertas S; Vural F; Vural F; Tufekci EC; Ertas AC; Kose G; Aka N
Asian Pac J Cancer Prev; 2016; 17(4):2177-83. PubMed ID: 27221915
[TBL] [Abstract][Full Text] [Related]
17. The risk of malignancy index (RMI) in women with adnexal masses in Wales.
Abdulrahman GO; McKnight L; Lutchman Singh K
Taiwan J Obstet Gynecol; 2014 Sep; 53(3):376-81. PubMed ID: 25286794
[TBL] [Abstract][Full Text] [Related]
18. Should cut-off values of the risk of malignancy index be changed for evaluation of adnexal masses in Asian and Pacific populations?
Yavuzcan A; Caglar M; Ozgu E; Ustun Y; Dilbaz S; Ozdemir I; Yildiz E; Gungor T; Kumru S
Asian Pac J Cancer Prev; 2013; 14(9):5455-9. PubMed ID: 24175841
[TBL] [Abstract][Full Text] [Related]
19. Comparison of risk of malignancy index (RMI), CA125, CA 19-9, ultrasound score, and menopausal status in borderline ovarian tumor.
Alanbay I; Akturk E; Coksuer H; Ercan M; Karaşahin E; Dede M; Yenen MC; Ozan H; Baser I
Gynecol Endocrinol; 2012 Jun; 28(6):478-82. PubMed ID: 22122561
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses.
Tingulstad S; Hagen B; Skjeldestad FE; Onsrud M; Kiserud T; Halvorsen T; Nustad K
Br J Obstet Gynaecol; 1996 Aug; 103(8):826-31. PubMed ID: 8760716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
